- Home
- Applications
- USA
- disease patient
Show results for
Refine by
Disease Patient Product Applications In USA
18 applications found
Heart failure is a disease with many stages. The onset may be rapid, or it may progress more gradually. But once heart failure starts; it usually becomes a lifelong disease that patients have to learn to live with. Living with heart failure can be easier once you understand the symptoms and can communicate with your health care providers to make sure you are receiving the right ...
ByImpulse Dynamics based in Marlton, NEW JERSEY (USA)
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
ByQynapse based in Paris, FRANCE
Deep brain stimulation (DBS) is a therapeutic approach that involves implanting electrodes in precise brain areas and fine-tuning the stimulation to alleviate symptoms such as in Parkinson’s disease. The variance in patient outcomes post-DBS is often linked to the optimization of DBS programming, which is inherently complex due to the multitude of adjustable parameters like contact points, polarity, frequency, pulse width, and amplitude. ...
ByGreat Lakes NeuroTechnologies based in Cleveland, OHIO (USA)
Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively. ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)
Zymeworks’ mission is to develop transformative treatments that help patients return home to their loved ones, disease-free. In order to bring new treatments to patients, we conduct clinical trials to assess the safety and efficacy of our investigational medicines. ...
ByZymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA)
Misdiagnosed Myocardial Ischemia, Heart Attack & Stroke Risk Leads to Poor Outcomes; Myocardial ischemia occurs when blood flow to your heart is reduced, preventing the heart muscle from receiving enough oxygen. This is often the result of plaque buildup inside the artery wall. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated.1 Current non-invasive testing cannot visualize the biology deep inside artery walls where heart ...
ByElucid based in Boston, MASSACHUSETTS (USA)
The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare ...
ByRareStone Group based in Shanghai, CHINA
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
Using our platform, we are developing mRNA medicines for diverse uses and delivering them to patients across the globe. We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
CROs can differentiate their services to sponsors with the white-labeled Jeeva eClinical technology platform advantage. Maximize the probability of winning contracts with sponsors by differentiating your proposals with Jeeva eClinical cloud. Sponsors want to know how you can ensure faster patient recruitment and better retention compared to your peers. Jeeva can rapidly turnaround with a budget proposal and branded material for inclusion in your response to sponsor RFPs and support you throughout the ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Etelcalcetide is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on hemodialysis.https://www.creative-peptides.com/product/etelcalcetide-item-10-101-140-34909.html ...
ByCreative Peptides based in New York, NEW YORK (USA)
We are driven to improve and extend the life of patients suffering from neurological diseases by providing an innovative technology for patients. ...
ByMonteris Medical based in Minnetonka, MINNESOTA (USA)
Isolating edited-pluripotent stem cells with traditional sorting techniques can subject the cells to rough conditions in which gene expression, genomic stability and overall cell-health can become compromised. Microfluidic cell sorting with the WOLF, along with single cell deposition using the N1 single cell dispenser, eliminates the challenges that pluripotent stem cells face by sorting at gentle pressures without decompression shock and shear stress, and allow for efficient single cell deposition for high ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
With Qynapse we all benefit from earlier and more accurate monitoring of patients. Patients, practitioners, researchers and you – the payer, all benefit from earlier, more accurate central nervous system disease diagnosis and monitoring of patients throughout the care continuum. Qynapse has the potential to help lower costs, drive up quality outcomes and improve patient satisfaction. Are you ready to transform neuroscience ...
ByQynapse based in Paris, FRANCE
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
ByAurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA)
Our flagship products, Virtue SAB and BackBeat CNT, have the potential to improve clinical outcomes and provide distinct commercial advantages within two of the largest and most well-established global medical device ...
ByOrchestra BioMed, Inc. based in New Hope, PENNSYLVANIA (USA)
For many years, researchers have investigated cell and gene therapies as potential replacement therapies for severe chronic diseases. Despite major advancements in the field, these approaches carry a number of limitations including immune rejection, limited eligibility, durability and variability challenges, inability to re-dose and high manufacturing costs. To address these drawbacks, we developed our novel Shielded Living Therapeutics™ (SLTx) platform, which we believe has the potential to ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)